$99.99
Selank and Semax are synthetic peptides studied for their potential effects on cognitive function, mood, stress response, and neurological health. This complementary blend combines Selank’s research interest in promoting calmness and emotional balance with Semax’s potential cognitive and neuroprotective properties.
10mg / 10mg
Selank and Semax are synthetic peptides originally developed and studied in Russia for their potential effects on the central nervous system. Selank is an analog of the naturally occurring immunomodulatory peptide tuftsin and has been investigated primarily for its potential anxiolytic (anxiety-reducing), stress-regulating, and cognitive effects. Semax is a synthetic peptide derived from fragments of adrenocorticotropic hormone (ACTH) and has been studied for its potential neuroprotective and nootropic (cognitive-enhancing) properties.
Together, Selank and Semax are of research interest for their potential complementary effects on mood, stress response, cognitive function, memory, focus, and neurological health. Research suggests these peptides may influence neurotransmitter systems and neurotrophic factors involved in brain function and neuroplasticity.
Medical Applications: Semax has been used medically in Russia and certain Eastern European countries for neurological applications, including recovery following ischemic stroke and other neurological conditions. Selank has also been studied in Russia for anxiety and stress-related disorders. Neither peptide is FDA-approved for medical use in the United States.
Research Applications: Selank and Semax are investigated in scientific research for their potential effects on neuroprotection, cognitive performance, stress response, anxiety, mood regulation, memory, and neuroplasticity.
Cognitive and Wellness Interest: Outside of established medical settings, the combination has gained interest for reported effects related to focus, mental clarity, motivation, memory, mood, and stress management. These applications remain experimental and have not been approved by the FDA.
Preclinical Studies: Animal and laboratory studies have investigated Semax for its potential influence on Brain-Derived Neurotrophic Factor (BDNF), neuroplasticity, oxidative stress, and cognitive function. Selank has been studied for its potential effects on neurotransmitter activity, stress responses, and anxiety-related behaviors.
Human Studies: Clinical research, primarily originating from Russia and Eastern Europe, has explored Semax in neurological recovery and cognitive function and Selank for anxiety and stress-related effects. Additional large-scale, independently replicated, peer-reviewed international studies are needed to establish their effectiveness and long-term safety.
Cognitive Function: Semax is being investigated for its potential role in supporting memory, focus, learning, and mental performance.
Stress and Anxiety Response: Selank is studied for its potential influence on anxiety, emotional balance, and the body’s response to stress.
Neuroprotection: Semax has been researched for its potential ability to support neuronal health and protect against certain forms of neurological stress or injury.
Mood Regulation: Both peptides have been investigated for their interactions with neurotransmitter systems involved in mood and emotional regulation.
Mental Clarity and Focus: The combination is of research interest for its potential effects on attention, cognitive fatigue, and mental performance.
Neuroplasticity Support: Semax’s potential influence on neurotrophic factors such as BDNF has made it an area of interest in research involving neuroplasticity, learning, and neurological recovery.
Complementary Research Potential: Combining Selank’s potential stress-regulating properties with Semax’s potential cognitive and neuroprotective effects has generated research interest in their possible complementary actions on overall neurological function.
